DOCUSATE SODIUM/SODIUM BENZOATE
Substance profile for UNII 656HXR6YXN, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- 656HXR6YXN
- Preferred term
- DOCUSATE SODIUM/SODIUM BENZOATE
- Registry number
- 121183-10-6
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C20H37O7S.C7H5O2.2Na
Chemical And Database Identifiers#
- SMILES
- [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1.CCCCC(CC)COC(=O)CC(C(=O)OCC(CC)CCCC)S([O-])(=O)=O
- RxCUI
- 0
- PubChem
- 71587449
- INN ID
- 0
Open Chemistry Sources#
| Source | Identifier | Link |
|---|---|---|
| PubChem Compound | 71587449 |  pubchem.ncbi.nlm.nih.gov/compound/71587449 |
| FDA Substance Registration System | 656HXR6YXN |  precision.fda.gov/uniisearch/srs/unii/656HXR6YXN |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| docusate sodium/sodium benzoate | INACTIVE INGREDIENT | 656HXR6YXN | TROKENDI XR (TOPIRAMATE) CAPSULE, EXTENDED RELEASE [SUPERNUS PHARMACEUTICALS, INC.] | 2 | |
| Docusate Sodium/Sodium Benzoate | INACTIVE INGREDIENT | 656HXR6YXN | EAR CLEANSING (ALCOHOL, LACTIC ACID, BENZOIC ACID, AND SALICYLIC ACID) LIQUID [VETOQUINOL USA, INC.] | 1 | |
| DOCUSATE SODIUM/SODIUM BENZOATE | INACTIVE INGREDIENT | 656HXR6YXN | FINASTERIDE TABLET [CIPLA USA INC.] | 1 |
Inactive Ingredient Database#
| Ingredient | UNII | CAS | Dosage form | Route | Potency | Maximum daily exposure |
|---|---|---|---|---|---|---|
| DOCUSATE SODIUM/SODIUM BENZOATE | 656HXR6YXN | 121183106 | CAPSULE | ORAL | 85 mg | |
| DOCUSATE SODIUM/SODIUM BENZOATE | 656HXR6YXN | 121183106 | CAPSULE, EXTENDED RELEASE | ORAL | 0.14 mg | |
| DOCUSATE SODIUM/SODIUM BENZOATE | 656HXR6YXN | 121183106 | TABLET | ORAL | 61 mg | |
| DOCUSATE SODIUM/SODIUM BENZOATE | 656HXR6YXN | 121183106 | TABLET, FILM COATED | ORAL | 6 mg |